This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Industry Symposia



GHS 2018 has been working with industry leaders to provide our delegates with a selection of unique educational sessions. Meals will be provided as part of the symposium.



Symposium: A Future Without Hepatitis C: What Will It Take? EPIC Talks Sponsored by Merck
Time: 12:30 PM - 2:00 PM | Room 718

EPIC (Expert Perspectives in Care) talks are short and compelling personalized narratives about the latest development in health care. This symposium will feature 3 talks:

  • “From Diagnosis to Cure: Breaking Down the Barriers to HCV Care”
  • “The Changing Landscape of Chronic HCV Treatment and Lessons from the Real World”
  • “HCV Elimination in Action: First Steps towards a Global Change”

*Lunch will be provided


Symposium: Clinical Implications for HE Management at the Boundaries: Prevention, Treatment and Palliative Care
Time: 6:00 PM - 7:30 PM | Room 717

The Symposium Objectives are:

  • The diagnosis of HE. Why is it an important condition?
  • Recommendations for HE treatment and the intersection of HE with palliative care
  • The case based fundamental of HE management from a nursing perspective 

*The dinner symposium is for Canadian healthcare and nurses only 
*Dinner will be provided




Symposium: Shaping Tomorrow Together: Learning as we make HCV Elimination a Reality
Time: 12:15 PM - 1:45 PM | Room 718

This symposium will feature talks on the following subject:

  • The changing face of liver diseases
  • The global commitment to eliminate viral hepatitis
  • Hot topics in HCV management

*Lunch will be provided



Symposium: Streamlining the Path to HCV Elimination Through Treatment Simplification 
Time: 12:30 PM - 2:00 PM | Room 718

This symposium will feature talks covering the following:

  • Treatment simplicity: What does this mean to you?
  • Special Populations: Are they 'special' anymore? 
  • HCV Elimination: Expanding the treater pool
  • High Risk Populations: High Reward
  • Will GT3 remain a challenge in the pangenotypic era? 

*Lunch will be provided